Profile
Magdalene K.
Cook is currently the President, Chief Executive Officer & Director at Renovacor Holdings, Inc. and also works as a Research Associate at the University of Virginia.
Previously, she served as the Chairman, President & Chief Executive Officer at Renovacor, Inc. from 2018 to 2022.
She has also worked as a Director at CardioKine, Inc., LabNow, Inc., and as a Principal at iKnowMed, Inc. Additionally, she served as a Board Observer at ArgiNOx Pharmaceuticals, Inc. and as a Principal at Aisling Capital LLC.
Dr. Cook received her undergraduate degree from the University of Virginia and her doctorate from Columbia University College of Physicians & Surgeons.
Magdalene K. Cook active positions
| Companies | Position | Start |
|---|---|---|
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy | Chief Executive Officer | 01/08/2018 |
Former positions of Magdalene K. Cook
| Companies | Position | End |
|---|---|---|
| RENOVACOR, INC. | Chief Executive Officer | 01/12/2022 |
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Private Equity Investor | 31/12/2006 |
iKnowMed, Inc.
iKnowMed, Inc. Internet Software/ServicesTechnology Services Provides physicians with on-line access to information across the network | Corporate Officer/Principal | - |
ArgiNOx Pharmaceuticals, Inc.
ArgiNOx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | - |
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology Develop drugs and pharmaceuticals for the treatment and prevention of heart failure | Director/Board Member | - |
Training of Magdalene K. Cook
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
iKnowMed, Inc.
iKnowMed, Inc. Internet Software/ServicesTechnology Services Provides physicians with on-line access to information across the network | Technology Services |
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology Develop drugs and pharmaceuticals for the treatment and prevention of heart failure | Health Technology |
ArgiNOx Pharmaceuticals, Inc.
ArgiNOx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
LabNow, Inc.
LabNow, Inc. Medical SpecialtiesHealth Technology Manufactures sensor technology systems | Health Technology |
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Finance |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University College of Physicians & Surgeons
Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy | Health Technology |
Renovacor, Inc.
Renovacor, Inc. BiotechnologyHealth Technology Engages in research and development for precision gene therapies and genetically driven cardiovascular diseases | Health Technology |
- Stock Market
- Insiders
- Magdalene K. Cook
















